NEAT1 and glioblastoma: We utilized qRT‐PCR to assess NEAT1 expression in clinical samples, comprising of 12 normal brain tissues, 37 primary GBM tissues, and 30 recurrent GBM tissues (insensitive to TMZ treatment).